Hidradenitis suppurativa
https://en.wikipedia.org/wiki/Hidradenitis_suppurativa
☆ AI Dermatology — Free ServiceDina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar. relevance score : -100.0%
References
What is hidradenitis suppurativa? 28209676 NIH
Hidradenitis suppurativa mangrupikeun kaayaan kulit kronis anu datang deui, sarta tiasa mangaruhan kahirupan anjeun sacara serius. Ieu disababkeun ku peradangan dina folikel rambut, sarta sering nyababkeun inféksi baktéri. Dokter biasana mendiagnosisna ku ningali rupa‑rupa luka (sapertos nodul, bisul, atanapi saluran sinus) anu biasana aya dina lipatan kulit, sarta ku nalungtik sabaraha sering luka datang deui jeung sabaraha lami éta tetep.
Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition. It is an inflammatory disorder of the follicular epithelium, but secondary bacterial infection can often occur. The diagnosis is made clinically based on typical lesions (nodules, abscesses, sinus tracts), locations (skin folds), and nature of relapses and chronicity.
Medical Management of Hidradenitis Suppurativa with Non-Biologic Therapy: What’s New? 34990004 NIH
Pangobatan non-biologis jeung non-prosedur biasana dipaké sorangan pikeun panyakit anu hampang, sarta bisa digabungkeun jeung terapi biologis jeung bedah pikeun panyakit sedeng nepi ka parah. Studi panganyarna nyayogikeun bukti tambahan ngeunaan efektivitas ngagunakeun corticosteroids nu disuntik langsung kana lesions pikeun HS flare-up jeung lesions localized. Saterusna, aya bukti nu nunjukkeun yén maké tetracyclines sorangan bisa jadi sakitu éféktifna saperti kombinasi clindamycin jeung rifampicin.
Non-biologic and non-procedural treatments are often used as monotherapy for mild disease and can be used in conjunction with biologic therapy and surgery for moderate to severe disease. Recent studies highlighted in this review add support for the use of intralesional corticosteroids for HS flares and localized lesions, and there is evidence that monotherapy with tetracyclines may be as effective as the clindamycin/rifampicin combination.
Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions 30924446Seueur pangobatan anu dianggo pikeun hidradenitis suppurativa, di antarana antibiotik, retinoid, antiandrogén, ubar nu ngahambat sistem imun, pangobatan anti radang, jeung radioterapi pikeun lesi awal. Pangobatan anu paling disarankeun nyaéta adalimumab jeung terapi laser. Bedah, boh eksisi saderhana atawa eksisi lokal lengkep jeung grafting kulit, mangrupakeun pilihan anu leuwih dipikaresep pikeun kasus anu parna atawa teu ngaréspon kana pangobatan séjén.
Many treatments are used for hidradenitis suppurativa, including antibiotics, retinoids, antiandrogens, immune-suppressing drugs, anti-inflammatory medications, and radiotherapy for early lesions. The top recommended treatments are adalimumab and laser therapy. Surgery, either simple excision or complete local excision with skin grafting, is the preferred option for severe, advanced cases that don't respond well to other treatments.
Pangna pasti can écés, tapi dipercaya ngalibatkeun kombinasi faktor genetik jeung lingkungan. Sakitar sapertilu jalma anu ngalaman panyakit boga anggota kulawarga anu ogé kapangaruhan. Faktor résiko séjénna kalebet obesitas jeung ngaroko. Kaayaan ieu henteu disababkeun ku inféksi atawa kabersihan anu goréng.
Teu aya ubar nu mujarab. Motong lesi anu kabuka pikeun ngidinan drainase teu méré kauntungan signifikan. Sanajan antibiotik sering dipaké, bukti efektivitasna masih lemah. Pangobatan immunosuppressive ogé tiasa dicoba. Pikeun pasien anu panyakitna parah, terapi laser atawa bedah pikeun ngaleungitkeun jaringan anu kapangaruhan tiasa dipertimbangkeun. Jarang, lesi kulit tiasa jadi kanker kulit.
Dina kasus hampang hidradenitis suppurativa, perkiraan prevalensina nyaéta 1‑4 % populasi. Awéwé kira‑kira tilu kali leuwih sering didiagnosis dibandingkeun lalaki. Gejala biasana muncul dina umur dewasa ngora.